- Home
- Technology advancing healthcare
Technology advancing healthcare
By combining deep understanding of technology and science with our people’s determination, we power the future of human health.
How Johnson & Johnson is helping healthcare providers remotely monitor and support patient health
Expertise, innovation and insight are fueling the development of remote and AI-powered approaches to healthcare—potentially improving treatment decisions and evolving the way clinical trials are designed and managed.
5 ways Johnson & Johnson is innovating in medicines and therapies
From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.
How surgery can harness the power of data to transform healthcare delivery
Data can help enhance clinical outcomes, improve efficiency in the operating room and personalize patient care—so long as it’s optimally collected and wisely used. Here, experts dive into its potential to elevate global standards of care.
6 ways Johnson & Johnson is using AI to help advance healthcare
Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.
How Johnson & Johnson is advancing the fight against Alzheimer’s disease
After decades of commitment to understanding this neurodegenerative disease, company scientists have developed therapies and tools that can potentially slow its progression and ease the psychological toll on patients and caretakers.
Introducing the first and only daily disposable multifocal contact lens for people with astigmatism
A Johnson & Johnson scientist explains how the new Acuvue® Oasys Max 1-Day Multifocal for Astigmatism contact lens also filters blue light, supports the eye’s natural tear film and helps eyes easily switch focus from distance to reading.
This scientist develops targeted treatments for cancer—here’s what drives and inspires him
Learn more about Robert Zhao, Ph.D, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.
Inside the decade-long effort to add digital tags to thousands of Johnson & Johnson MedTech products
Efficiently tracking medical devices can cut down on injuries and errors. But until recently, there was no industry-wide standard for doing it. Unique Device Identifiers, a new kind of label, are changing that.